JMC Corporation
5704・Growth Market・Nonferrous Metals
3D Printer Business
High-margin segment offering resin 3D printer-based prototyping, AM services, and medical simulators
| Period | Current | Previous | Change |
|---|---|---|---|
| Sales (Q1 cumulative) | ¥169 million | ¥171 million | ↓ |
| Segment profit (Q1 cumulative) | ¥53 million | ¥52 million | ↑ |
| Segment profit margin (Q1 cumulative) | 31.4% | 30.1% | ↑ |
| Number of units sold (Q1 cumulative) | 457 units | - | — |
Business Details
Provides prototype manufacturing and AM services using resin 3D printers covering major fabrication methods such as stereolithography, powder sintering, and FDM. In addition to industrial prototype output services, the segment also handles manufacturing and sales of the HEARTROID cardiac catheter simulator, as well as data editing and manufacturing of Medical Models (Life-Size Models). Customers span a wide range of industries including wholesale trade (40.0% of sales) and precision machinery/medical device manufacturing (16.1%). This is a high-profitability business that maintains the highest margin among all company segments.
Recent Overview
HEARTROID overseas project saw delivery delays, but output service order volume increased
In Q1 of FY2026 (ending December 2026), delivery delays and other issues occurred on some overseas customer projects for HEARTROID, resulting in sales of ¥169 million (down 1.5% year on year), a slight decrease. Meanwhile, in the output service area, molding proposals addressing mockup needs for exhibitions and events, in addition to industrial part prototyping, were successful and order volume increased. Cost efficiency improvements resulted in segment profit of ¥53 million (up 2.5% year on year), securing a profit increase.
Key Products
Growth Drivers
- Expanding sales of the HEARTROID cardiac catheter simulator to domestic and overseas medical institutions and device manufacturers
- Expanding output service orders by addressing diverse molding needs such as mockups for exhibitions and events
- Improving order fulfillment speed for industrial prototype output services through expanded molding variations
- Strengthening order acquisition capability through expansion and training of sales personnel
- Promoting the establishment of the AM Service (mass-production order framework)
- Expanding the customer base into the medical and healthcare fields
Risks
- HEARTROID adoption depends on medical institutions' decision-making, creating risk of order concentration and volatility (delivery delays for overseas customers have already occurred)
- Rapid evolution of 3D printer technology may intensify competitor entry and price competition
- Risk of leakage of confidential information related to customers' product development
- Risk of reputational damage in the event of product defects or quality issues with medical products (HEARTROID)
- Impact on profitability from rising equipment and material costs
Last updated: March 24, 2026